Effect of intraduodenal administration of 23-methyl-UDCA diastereoisomers on bile flow in hamsters.
3 alpha,7 beta-Dihydroxy-23-methyl-5 beta-cholan-24-oic acid (MUDCA) and its two diastereoisomers, alpha- and beta-MUDCA, were infused intraduodenally in biliary fistula hamsters in order to evaluate the effect on bile flow and their hepatic biotransformation processes compared with the natural analog ursodeoxycholic acid (UDCA). In addition, the corresponding glycine conjugates were compared. The bile acids were administered at different doses (0.7-6 mumol/min/kg) over periods of 90 min. The results indicate that the racemic mixture exhibits a potent choleretic effect at both low and high doses, while the two individual diastereoisomers show this effect only at high doses. The presence of a C-23 methyl group in the side chain prevents hepatic amidation and alternative conjugations occur, such as glucuronidation, in order to facilitate their biliary secretion. Biotransformation of the methyl derivatives of UDCA occurred mainly by conversion to more polar glucuronide conjugates. There was little alteration to the molecule and, unlike UDCA, very little amidation occurred. These data indicate that the presence of a C-23 methyl group prevents the usual side-chain amidation common to the most naturally occurring bile acids and that glucuronidation is a requisite for efficient biliary excretion.
Clerici
C
C
Istituto di Gastroenterologia, Università degli Studi di Perugia, Italy.
Dozzini
G
G
Distrutti
E
E
Gentili
G
G
Sadeghpour
B M
BM
Natalini
B
B
Pellicciari
R
R
Rizzoli
R
R
Roda
A
A
Pelli
M A
MA
D000208:Acute Disease; D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D001646:Bile / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D001658:Biliary Fistula / Q000378:metabolism; D001711:Biotransformation; D006224:Cricetinae; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004386:Duodenum; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008647:Mesocricetus; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology
D001639:Bicarbonates; C069594:23-methylursodeoxycholic acid; C024033:glycoursodeoxycholic acid; D014580:Ursodeoxycholic Acid